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Abstract
Transfer RNAs decode messenger RNA using anticodon – codon interactions to deliver specific
amino acids to a growing peptide chain. Enzyme-catalyzed modifications on specific nucleotides
on tRNAs increase their stability and help mediate the speed and fidelity of translation, giving
these modifications regulatory potential. RNA modifications are catalyzed by writer enzymes, and
I predicted that writers are important in the cellular responses to stress. I have evaluated the
following E. coli modification enzyme mutants: miaA, mnmE, dtd, tmcA, lysU, yeaK, and iscS,
from the corresponding Keio E. coli gene deletion library. Writer mutants were exposed to
hydrogen peroxide to induce an oxidative stress response. The knockouts of iscS (which transfers
sulfur to tRNA), miaA (which transfers dimethylallyl to tRNATyr and tRNAPhe), and tmcA (which
aceylates the wobble base on tRNAMet) showed growth sensitivity to hydrogen peroxide.
Additional gene deletion mutants were also sensitive including those encoded by tusA/tusC/tusD
(sulfur mediators), mnmA (catalyzes 2-thiouridine modification), and iscU (scaffold protein,
works with iscS). Sulfur transfer to tRNA was highlighted to be important in the response to
hydrogen peroxide, as several gene deletions in this pathway exhibit sensitivity to oxidative stress,
and it is possible that the sulfurtransferase pathway is critical to the oxidative stress
response. Existing literature shows that sulfurtransfer is also critical in the oxidative stress
response in mice and humans (Nakajima, 2015). Computational work was also performed using
the Basic Local Alignment Search Tool (BLAST) and the Search Tool for the Retrieval of
Interacting Genes/Proteins (STRING), which were used to discover connections between bacterial
genes and to human orthologs. A connection to disease was found for tmcA and miaA and iscS,
as their human orthologs are linked to oxidative phosphorylation deficiency disorders. Ultimately,
my project has provided insight into the role of writers in the response to oxidative stress.
Keywords: Oxidative stress, Hydrogen peroxide, tRNA modification, Sulfurtransferase,
Interaction network
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Introduction
The process of generating protein begins when instructional DNA is transcribed to form
messenger RNA (mRNA). The mRNA is then translated to protein. The mRNA binds to the
ribosome, and a tRNA for AUG- the “start” codon- binds to the matching mRNA segment to begin
the process of translation. The tRNA continues to decode the mRNA strand using codon-anticodon
interactions, building a peptide composed of individual amino acids that correspond to the mRNA
sequence (Crick, 1970).
The third base in each codon has slightly different pairing rules than the first two: instead
of strictly bonding to one base, this third position has several options for partner bases. The
anticodon base guanine (G), which usually only binds to cytosine (C), can also bind to uridine (U).
Anticodon base C can still only bind G, however. Anticodon base adenine (A) can bind to uridine
(U), but a U anticodon base can bind to both A and G. There is also a special anticodon base called
inosine (I) that can bind to A, U, and C. This flexibility is known as wobble pairing, and it allows
tRNA to decode multiple codons. For example, the gene mnmE encodes a protein that is required
to form the 5-methylaminomethyl-2-thiouridine modification on tRNA, which stabilizes wobble
pairing for the U-G base combination (Elseviers et al., 1984b).
When a tRNA brings an amino acid to the ribosome, it must effectively bind to the
aminoacyl site (for initial binding), the peptidyl site (for polypeptide extension), and the exit site
of the ribosome in that sequence (Griffiths, 2008). The tRNA specific to the amino acid tyrosine
requires a specific modification to make this connection efficiently. The addition of a dimethylallyl
to the N6 position of A37- is mediated by the product of the miaA gene, which is responsible for
the transfer of the group (Rosenbaum & Gefter, 1972).
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When an amino acid chain is being assembled, it is critical that the proper stereoisomers,
which are molecules with the same atoms, but a different spatial orientation, are inserted into the
chain. The incorrect stereoisomer could prematurely terminate the chain, as it would be facing in
the incorrect direction and could preclude peptide chain elongation. Special erasers exist to ensure
that the incorrect stereoisomers are not introduced into polypeptides. The protein encoded by the
dtd gene is one of these, as it is responsible for releasing tRNA tyrosine from the incorrect Dtyrosine (as opposed to the correct L-tyrosine) (Soutourina et al., 1999).
When the ribosome and mRNA strand interact to assemble a polypeptide sequence, specific
tRNAs for each amino acid bring that amino acid to the binding site. Thus, it is critical that these
tRNAs are bound to the amino acid that corresponds to the mRNA codon being translated. If the
tRNA is mischarged, the incorrect amino acid will be inserted into the polypeptide, likely
producing a nonfunctional protein. To avoid this, enzymes exist to deacylated mischarged tRNAs,
removing the incorrect amino acid. yeaK (also known as ProXP) is one of these enzymes,
responsible for the deacylation of Ser- and Thr- tRNAs (Liu et al., 2015b).
Wobble pairing allows for a wider range of amino acids to be coded for than would
otherwise be possible under strict A-T G-C pairing. Ensuring the fidelity of wobble pairing is
essential to prevent mistranslation, and as such, modifications are made to the anticodon loop to
increase the precision of codon recognition. One such modification is N4-acetylcytidine catalyzed
by tmcA. This modification helps the tRNA differentiate between the similar AUG and AUA
codons, ensuring that only AUG acts as an elongation codon (Ikeuchi et al., 2008a).
Another modification that acts near the anticodon loop is 6-threonylcarbamoyladenosine
on position 37, which is catalyzed by tsaE. This modification acts to preserve translational fidelity
by increasing codon recognition and stabilizing codon-anticodon interaction (Zhang et al., 2015).
2

As previously discussed, the process of translation involves specific tRNAs bringing their
corresponding amino acid to the ribosome to be added to the polypeptide chain. The specificity of
these tRNA molecules is essential; the addition of an incorrect amino acid could create a
nonfunctional protein. To preserve the specificity of tRNA, there are specialized binding enzymes
that attach a tRNA to its proper amino acid. One such binding enzyme, phenylalanine-tRNA ligase
(PheRS), is a tetramer composed of two alpha subunits and two beta subunits. The creation of the
alpha subunits is the responsibility of pheS (Comer & Böck, 1976).

Figure 1. MnmE Catalyzed Modification (Pearson & Carell, 2011)
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This figure shows how mnmE fits in the pathway for 5-methylaminomethyl-2-thiouridine
synthesis. Specifically, mnmE catalyzes the addition of a carboxymethylaminomethyl group to
selenouridine.

Figure 2. MiaA Catalyzed Modification (Esberg et al., 1999)
The molecule dimethylallyl pyrophosphate is used to provide a dimethylallyl group, which is
added to A37. The writer MiaA catalyzes the formation of the N6-isopentenyladinosine
modification.
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Figure 3. Function of Dtd (Bhatt et al., 2016)
Shown in this illustration is the effect of Dtd on protein synthesis. The polypeptide chains
produced, drawn on the right of the image, show that the wrong stereoisomer of tyrosine can create
a nonfunctional protein.
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Figure 4. Structure of YeaK (Liu et al., 2015a)
This diagram shows the deacylation targets of YeaK (also known as ProXp). The bulleted lists
show the subgroups of each target, and to the right the causes of each misacylation is shown.
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Figure 5. Structure and Position of TmcA (Ikeuchi et al., 2008b)
The illustration on the left is the chemical structure of the modification that TmcA catalyzes- N4‐
acetylcytidine. This position on the tRNA molecule can be seen in the illustration to the right; it is
the 34 position, also known as the wobble position.
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Figure 6. Structure and Position of TsaE (Deutsch et al., 2012)
The illustration on the right shows the chemical structure of t6A, which is the modification
catalyzed by TsaE. To the left, the modification’s position on the tRNA molecule is shown; it acts
on the 37 position, near the anticodon loop.

8

Figure 7. Protein Structure and Mutations of PheRS Enzyme (Ponmani & Munavar, 2014)
This image shows the detailed protein structure of the PheRS enzyme, which PheS is partially
responsible for. This enzyme links phenylalanine amino acids to the matching tRNA molecules,
and it thus important for translation. The image also shows several amino acid changes that can
occur in this enzyme and how those mutations can affect the structure.
Oxidative stress occurs as a result of normal cellular metabolism. Many metabolic
pathways- such as the electron transport chain and metal catalyzed oxidation- produce reactive
oxygen species as by-products or intermediates, and these chemicals must be detoxified before
they oxidize and damage DNA, RNA, or protein (Cabiscol-Català et al., 2000). The program of
detoxification is called the oxidative stress response, and it involves changes in the expression of
the cell’s DNA. For example, oxidative stress has been shown to increase expression of the genes
9

that encode for the glutathione peroxidase, catalase, Cu,Zn-superoxide dismutase, and Mnsuperoxide dismutase antioxidant enzymes (Franco et al., 1999). By removing specific genes and
stressing the mutants, we will be able to see if those genes are essential to the stress response.
To obtain knockouts mutants of our test genes, we used the Keio E. coli library (Baba et
al., 2006). Each strain has a single gene that has been replaced with a sequence that gives the
mutant resistance to the antibiotic kanamycin. Each knockout is achieved using homologous
recombination, a process by which two similar nucleotide strands exchange genetic information
(Capecchi, 1989). This serves the dual function of knocking out the desired gene and allowing for
the bacteria to be kept free of contamination (by using kanamycin, as it will kill any non-mutant
cells.
There are also human RNA modification enzymes and marks that are important. NAT10
is responsible for catalyzing the N(4)-acetylcytidine modification, which increases translational
stability (Sharma et al., 2015). TRIT1 catalyzes the transfer of a dimethyl group to the adenine on
the 37 position of tRNA, leading to the formation of an N6-dimethylallyladenosine modification
(Spinola et al., 2005). CDK5RAP1 catalyzes the conversion of N6-dimethylallyladenosine to 2methylthio-N6-dimethylallyladenosine at position 37, which enhances the efficiency and accuracy
of translation (Reiter et al., 2012). GTPBP3 helps create a 5-carboxymethylaminomethyl
modification on the wobble uridine base of tRNA (Bykhovskaya et al., 2004). FARSA is
responsible for one subunit of the phenylalanine-synthetase complex, which charges tRNAs with
phenylalanine (Rodova et al., 1999). FARSB is responsible for the sister subunit to FARSA, which
is also a part of the phenylalanine-synthetase complex (Rodova et al., 1999). SARS helps to attach
serine to tRNASer (Xu et al., 2013). SARS2 also helps to attach serine to tRNASer, and it may also
be involved in the process of creating selenocysteine (Yokogawa et al., 2000). KARS catalyzes
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the addition of lysine to tRNALys, and it can also be secreted as a signaling molecule (Shiba et al.,
1997). DUS4L catalyzes the synthesis of dihydrouridine, a modified base (Ota et al., 2004). DTD1
deacylates mischarged D-aminoacyl-tRNAs, and it may also be connected to DNA replication
(Casper et al., 2005). DTD2 also deacylates mischarged D-aminoacyl-tRNAs, and it also catalyzes
the hydrolysis of D-tyrosyl-tRNATyr (Kuncha et al., 2018). MTRF1L is involved in the termination
of translation in response to the UAA and UAG codons; it is a release factor that stimulates the
protein’s separation from the ribosome-tRNA complex (Soleimanpour-Lichaei et al., 2007).
TRMO is a methyltransferase that adds a methyl group to form N6-methyl-N6threonylcarbamoyladenosine at position 37 (Kimura et al., 2014). TST is involved in forming ironsulfur complexes, detoxifying cyanide, and converting thiosulfate and cyanide to thiocyanate and
sulfite (Aita et al., 1997).
In my project I tested the sensitivity of several KEIO mutants by spotting them on plates
with varying concentrations of hydrogen peroxide. Additionally, computational analysis was
performed on each enzyme specific to my tested genes using several databases to explore the
writers’ potential connection to human disease. Initially, BLAST was performed to identify which
genes have human equivalents. Those that have human equivalents were evaluated in the National
Cancer Institute Data Portal and The Human Protein Atlas to find connections to cancer and
disease. Although their functions are often discussed on an individual basis, genes do not exist in
isolation. In the complex environment of the cell, genes- and their protein products interact with
each other to form interaction networks. These interactions can be both direct, in which proteins
physically interact to perform their functions or form multi-protein complexes, or indirect, in
which proteins are involved in similar functions or related pathways (Szklarczyk et al., 2015).
Investigating these interaction networks can yield information about the genes being investigated
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and about the functions they perform. This investigation was performed using the STRING
Database, which compiles interactions between genes and generates images of interaction
networks. The in-laboratory and computational experiments with bacterial writers have established
a potential connection between the sulfur relay system that leads to the synthesis of the 2thiouridine modification (along with its downstream derivatives, mnm5s2u and cmnm5s2u) in
tRNA; to further explore these connections and to make the findings more applicable to human
biology, an investigation of human genes was necessary. This is the purpose of the STRING
interaction network analysis. Of the five bacterial genes that were found to have human orthologs,
the data indicates that there may be a connection between miaA and TmcA and several types of
cancer; however, there does not seem to be a link between any writer and brain disease. The
network of human writers was found to have a strong connection to both tRNA modification
activity and ligase activity, which is the bonding of tRNAs to their specific amino acid. Several of
the genes identified as being important for the response to oxidative stress are linked to
sulfurtransferase function. This is a broad category that includes any enzyme that acts on or
interacts with sulfur atoms or compounds, with some tRNA modifications involved in the addition
of sulfur. Fugure 8 highlights an example of a gene that acts as a sulfurtransferase with regards to
tRNA is iscS, which catalyzes the transfer of sulfur from cysteine to tRNA as part of the synthesis
of the 4-thiouridine modification (Kambampati & Lauhon, 1999).
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Figure 8. Sulfurtransferase Pathway (Kambampati & Lauhon, 1999)
This image shows the pathway that leads to the transfer of sulfur to tRNA. At the beginning, on
the left side of the image, iscS is shown. Immediately after is tusA, with the rest of the tus family
following immediately downstream. MnmA and several other mnm family genes are found at the
end of the pathway. These genes were part of this experiment’s investigation into the sensitivity
of E. coli to hydrogen peroxide.
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Materials and Methods
LB agar media was used to plate the cells. To make LB agar media, 100 mL of distilled
water was added to a 1000 mL autoclaved bottle, then 12.5 g of LB media (Fisher Scientific,
Agawam, Massachusetts) was added along with enough distilled water to bring the total volume
to approximately 500 mL. A stir rod and 7.5 g of agar (Fisher Scientific) was added to the bottle
and it was stirred for a short period until it appeared mixed. The bottle was then placed in a metal
tray and the cap was loosened to prepare it to be autoclaved on a liquid cycle for two hours. The
autoclaved bottle was then gently stirred on a stir plate for one hour to cool down. The media was
then poured out onto plates, which were left upside down in the 55 OC incubator to dry for
approximately 15 minutes (Iacoviello & Rubin, 2001).
LB plates with H2O2 were made with media using a similar method as described above.
This media was added to a tube along with an amount of hydrogen peroxide (Fisher Scientific,
Agawam, Massachusetts) to yield the desired concentration. This amount varied, as there were 8
different concentrations plated. After the media and hydrogen peroxide were gently mixed, the
tube was poured into a plate.
E. coli colonies were first obtained using LB plates. The desired strain of mutant was pulled
from the Keio collection in the -80 OC freezer, and a metal loop was used to gather a clump of
cells. These cells were then streaked across one of the LB agar plates containing kanamycin (5
ug/mL). The loop was flame sterilized using a Bunsen Burner in between each use. The streaked
plates were then left to grow at 37 OC for 24 hours.
Overnight tubes were made once the E. coli colonies had grown to a sufficient level. One
tube with LB kanamycin liquid media was prepared for each strain and a single bacterial colony
was added. Another tube was made with a wild type colony in LB media. These tubes were
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incubated overnight, and the next day they were used to spot the strains. Using a multichannel
pipette, a five-fold serial dilution was performed seven times for each strain. The dilutions were
spotted across several different plates containing an increasing concentration of hydrogen
peroxide.
RNA Extraction was performed on four different experimental strains of E. coli, as well
as a WT strain and a negative control strain. To perform the extraction, a previously prepared
Overnight Tube containing the strain of interested is placed in a centrifuge to pellet the bacteria.
TRIzol reagent and chloroform are added to separate out the RNA, which was removed and repelleted. Ethanol and isopropanol were added and subsequently removed, and the final pellet is
suspended in RNase-free water. This absorption of this solution is then analyzed to determine the
concentration of RNA present and the purity of said RNA (Rio et al., 2010).
A Nanodrop Spectrophotometer was used to evaluate the extracted RNA. This device
passes light through a liquid sample and measures how much light is absorbed by the sample at
different wavelengths. By comparing two different wavelengths ratios, we are able to evaluate the
purity of the RNA sample. The 260:280 ratio describes the presence of DNA contamination. The
260:230 ratio describes the presence of ethanol and propanol contamination (Desjardins &
Conklin, 2010a). For both ratios, a value of approximately 2.0 is considered pure and relatively
free of contamination. The Nanodrop also gives results about the concentration (in nanograms per
microliter) of RNA present in the sample (Desjardins & Conklin, 2010b). The results from the
RNA Extraction of dtd knockouts are shown in Table 2.
Computational Analysis was performed using several tools to investigate the genes of
interest. The first step in this analysis was to use BLAST to compare the DNA and amino acid
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sequence of each gene product to the human genome to look for human homologs (McGinnis &
Madden, 2004).
This process was augmented by the Ecocyc Database. This tool uses gene ontology termsa set of common vocabulary used to describe genes and proteins- and compares the description of
a gene of interest to multiple other databases (Ashburner et al., 2001). For this search, each gene
was compared against the human genome.
Information about the specific tRNA modifications encoded for by the genes of interest
was found in the MODOMICS database. This database contains information on all known tRNA
modifications, and it is useful for finding names, structures, and enzymatic activities. It is also a
useful resource for finding more detailed research on a particular modification (Boccaletto et al.,
2018).
For the five genes that were found to have human orthologs, further computational work
was done. This began in The Cancer Genome Atlas, which contains extensive data connecting
human genes to cancer. This data was used to create a graph for each gene that detailed the survival
rate of patients with a cancer containing single nucleotide changes or copy number variations in
that particular gene (Jensen et al., 2017). These graphs are shown in Figure 9.
For the two genes that showed a potential connection to cancer in the Cancer Genome Atlas
data, more work was done in The Human Protein Atlas (Pontén et al., 2008). This database has
data on human proteins, and it was used to provide more specific graphs that connect the amount
of protein expression to specific types of cancer. This database was also used to look at the
localization of all five human-homolog proteins in the brain. The HPA results are shown in Figures
10 and 11.
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These five human homologs were further investigated in an analysis of gene interaction
networks. To provide a more substantial analysis, ten additional genes were selected. These were
chosen by finding bacterial genes with inferred or established relationships to the original five,
then using the BLAST tool to find their human homologs. The function of each gene will be briefly
described to give an initial overview of the function of the interaction network.
The STRING Database is a computational tool used for evaluating interaction networks.
It contains a collection of known and predicted protein-protein interactions. These interactions are
taken from existing literature and experimentation, predicted based on gene co-expression/cooccurrence and gene neighborhood, or predicted through text-mining and protein homology
(Szklarczyk et al., 2019). These interactions are visualized using a 2-dimensional web of nodes
and lines. Along with this visualization are tables that statistically describe the biological processes
and molecular functions associated with the network. For all fifteen writers of interest, a network
and table were generated. The first was created by inputting all fifteen writers, which resulted in a
fifteen-node network that showed how the writers interacted amongst each other. The second was
generated by compiling a list of all of the genes contained in each individual writer’s network and
using this list as the input; this network expanded on the previous compilation network by showing
the interactions of not just the original fifteen writers, but their entire individual networks as well.
To conclude the STRING data evaluation, each writer’s false discovery rate with relation
to several of the network’s most notable biological processes and molecular functions was
determined. False discovery rate is a corrected p value, and it serves as a measure of the
significance of a particular enrichment (Benjamini, 2010). For Table 3, a lower false discovery
rate indicates a stronger connection between the writer and the process. The table was created by
using STRING’s built-in analysis tables to select several biological processes and molecular
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functions, then observing the writers associated with each. The strength of the false discovery rate
is visually indicated by the color of its individual square, with a warmer color indicating a lower
number.
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Results
To determine a knockout’s response to oxidative stress, a Sensitivity Screen is required.
To perform this, several E. coli mutants were grown on several LB media plates with varying
concentrations of hydrogen peroxide for calibration purposes. These plates indicated that the
bacteria grew at a hydrogen peroxide concentration of 0.258 mM, but they were killed off by a
hydrogen peroxide concentration of 1.29 mM. The results of this screen are seen in Figure 9.
Additional screens, pictured in Figure 10, were conducted to provide a more precise range at which
E. coli growth could be observed. These screens indicated that the concentration range could be
further reduced to 0.258 mM to 0.348 mM.

Figure 9. E. coli Growth Results
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These pictures show the bacteria’s growth for the 0.258 mM and 1.29 mM concentrations. The
first row is wild-type E. coli, the second and third rows are Δdtd, the fourth and fifth rows are
ΔmiaA, and the last two rows are ΔmnmE.

Figure 10. E. coli Growth Results Part 2
These images show bacterial growth at the concentrations 0.361 mM and 0.464 mM hydrogen
peroxide. The bacterial colonies do not grow at a useful level at these concentrations, so future
growth tests should be conducted at lower concentrations.
The following figures are the result of several hydrogen peroxide screens. Each was
conducted with a new set of mutant E. coli strains to gauge their individual sensitivities to the
oxidative stress provided by the hydrogen peroxide.
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0.348 mM H2O2
WT
dtd
lysU
tmcA
mnmE
yeaK
iscS
miaA
Figure 11a. First Sensitivity Trial
These images are the results of the first set of sensitivity trials. The images each show the growth
of several different E. coli mutants in the presence of hydrogen peroxide. The concentration of
hydrogen peroxide is listed above each plate. The Mutant strains are identified to the left of the
image. Each mutant underwent a seven-time dilution, with each stage of the dilution being spotted
on the plate. Thus, the concentration of bacteria decreases from left to right across each image.
0.288 mM H2O2
WT
dtd
lysU
tmcA
mnmE
yeaK
iscS
miaA
Figure 11b. Sensitive Mutants from First Trial
The four mutants that express a potential growth deficiency are indicated by red squares. IscS
shows very weak growth, with only one colony of growth. TmcA and mnmE both show fairly low
growth in relation to the other strains, with spotty growth after the first colony. miaA shows a
potential growth deficiency, as its growth is weak after the first colony. However, growth does
continue in this weakened state- further evaluations of miaA were required.
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iscS STRING Map

miaA STRING Map
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tmcA STRING Map

mnmE STRING Map

Figure 11c. STRING Networks for Sensitive Mutants
These networks show the process of identifying new mutants for the second trial based on those
found to be sensitive in the first trial. Each network shows the close genetic relatives of one
sensitive gene, which is circled in red and indicated in the label above each image. The red arrows
24

indicate the new mutant that was selected for the second trial. The gene mnmA was found in both
the mnmE and iscS networks, making it a priority target. HscB was also selected from the iscS
network. RspA was selected from the tmcA network. No new genes were selected from miaA, as
its sensitivity was still uncertain.
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0.348 mM H2O2
WT
iscS
hscB
mnmE
mnmA
tmcA
rspA
miaA
Figure 12a. Second Sensitivity Trial
These images are the results of the second set of sensitivity trials. The images each show the growth
of several different E. coli mutants in the presence of hydrogen peroxide. The concentration of
hydrogen peroxide is listed above each plate. The Mutant strains are identified to the left of the
image. Each mutant underwent a seven-time dilution, with each stage of the dilution being spotted
on the plate. Thus, the concentration of bacteria decreases from left to right across each image.

0.348 mM H2O2
WT
iscS
hscB
mnmE
mnmA
tmcA
rspA
miaA
Figure 12b. Sensitive Mutants from Second Trial
The three mutants that express a potential growth deficiency are indicated by red squares. IscS
once again shows very weak growth. As predicted by its relationship to iscS and mnmE, mnmA
shows a strong sensitivity, with no growth on this plate. MiaA shows a similar lack of growth,
indicating that it is likely sensitive. However, we must also consider the wild type control. In this
trial, the wild type exhibited very little growth, removing the positive control. Relative growth

27

between strains can still be observed, but- without a control- conclusions cannot be definitively
drawn from this trial.

iscS STRING Map

miaA STRING Map
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mnmA STRING Map

Figure 12c. STRING Networks for Sensitive Mutants
These networks show the process of identifying new mutants for the third trial based on those
found to be sensitive in the second trial. Each network shows the close genetic relatives of one
sensitive gene, which is circled in red and indicated in the label above each image. The red arrows
indicate the new mutant that was selected for the third trial. Given their more stark growth
deficiencies, mnmA and iscS were given priority over miaA. ThiI was identified in both netwroks,
making it a priority. The same is true of tusA. MnmG was also taken from the mnmA network. Fdx
was taken from the iscS network.
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0.348 mM H2O2
WT
iscS
mnmA
miaA
thiI
tusA
fdx
mnmG
Figure 13a. Third Sensitivity Trial
These images are the results of the third set of sensitivity trials. The images each show the growth
of several different E. coli mutants in the presence of hydrogen peroxide. The concentration of
hydrogen peroxide is listed above each plate. The Mutant strains are identified to the left of the
image. Each mutant underwent a seven-time dilution, with each stage of the dilution being spotted
on the plate. Thus, the concentration of bacteria decreases from left to right across each image.

0.258 mM H2O2
WT
iscS
mnmA
miaA
thiI
tusA
fdx
mnmG
Figure 13b. Sensitive Mutants from Third Tria[
The three mutants that express a potential growth deficiency are indicated by red squares. IscS
continues to show a strong sensitivity. MnmA also shows a similar pattern. As predicted based on
its prescence in both the iscS and mnmA networks, tusA shows a severe lack of growth.
Interestingly, miaA- previously thought to be sensitive- has an amount of growth comparable to
the other seemingly uneffected mutant strains. Also of note, the prediction that thiI would be
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sensitive appears to be incorrect. However, this trial also has very weak wild type growth. This
removes the positive control. Relative growth between strains can still be observed, but- without
a control- conclusions cannot be definitively drawn from this trial.

iscS STRING Map

mnmA STRING Map
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tusA STRING Map

Figure 13c. STRING Networks for Sensitive Mutants
These networks show the process of identifying new mutants for the fourth trial based on those
found to be sensitive in the third trial. Each network shows the close genetic relatives of one
sensitive gene, which is circled in red and indicated in the label above each image. The red arrows
indicate the new mutant that was selected for the fourth trial. From the iscS network, cyaY was
selected. HflD (listed as ycfC below) was chosen from the mnmA network. TusC and tusD were
both selected from the tusA network.
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0.348 mM H2O2
WT
iscS
mnmA
tusA
cyaA
ycfC
tusC
tusD
Figure 14a. Fourth Sensitivity Trial
These images are the results of the fourth set of sensitivity trials. The images each show the growth
of several different E. coli mutants in the presence of hydrogen peroxide. The concentration of
hydrogen peroxide is listed above each plate. The Mutant strains are identified to the left of the
image. Each mutant underwent a seven-time dilution, with each stage of the dilution being spotted
on the plate. Thus, the concentration of bacteria decreases from left to right across each image.

0.258 mM H2O2
WT
iscS
mnmA
tusA
cyaA
ycfC
tusC
tusD
Figure 14b. Sensitive Mutants from Fourth Trial
The five mutants that express a potential growth deficiency are indicated by red squares. IscS,
mnmA, and tusA all show a growth deficiency, continuing their pattern. The relatives of tuA, tusC
and tusD, also show a lack of growth, as they failed to grow past the second colony.
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iscS STRING Map

mnmA STRING Map
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tusA STRING Map

tusC STRING Map
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tusD STRING Map

Figure 14c. STRING Networks for Sensitive Mutants
These networks show the process of identifying new mutants for the fifth trial based on those found
to be sensitive in the fourth trial. Each network shows the close genetic relatives of one sensitive
gene, which is circled in red and indicated in the label above each image. The red arrows indicate
the new mutant that was selected for the fifth trial. IscU and tusE were selected due to their
presence in several of the networks. Based on these close relations to several sensitive genes, I
predict that these genes will also show a sensitivity.

38

0 mM H2O2
WT
iscU
tusA
tusC
tusD
tusE
mnmC
ytfE
0.258 mM H2O2
WT
iscU
tusA
tusC
tusD
tusE
mnmC
ytfE
0.288 mM H2O2
WT
iscU
tusA
tusC
tusD
tusE
mnmC
ytfE
0.318 mM H2O2
WT
iscU
tusA
tusC
tusD
tusE
mnmC
ytfE

39

0.348 mM H2O2
WT
iscU
tusA
tusC
tusD
tusE
mnmC
ytfE
Figure 15a. Fifth Sensitivity Trial
These images are the results of the fourth set of sensitivity trials. The images each show the growth
of several different E. coli mutants in the presence of hydrogen peroxide. The concentration of
hydrogen peroxide is listed above each plate. The Mutant strains are identified to the left of the
image. Each mutant underwent a seven-time dilution, with each stage of the dilution being spotted
on the plate. Thus, the concentration of bacteria decreases from left to right across each image.
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0.258 mM H2O2
WT
iscU
tusA
tusC
tusD
tusE
mnmC
ytfE
Figure 15b. Sensitive Mutants from Fifth Trial
This trial was noteworthy in that all strains- including the control- showed a remarkably low
growth, even at low hydrogen peroxide concentrations. This makes the attribution of sensitivity or
the lack thereof difficult. However, some mutants did show less growth than the others. The
previously tested tusA, tusC, and tusD all failed to grow at any concentration. New testee iscU, a
relative of the consistently sensitive iscS, also failed to grow. This indicates a potential sensitivity.
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The following table shows the compiled results of the previous sensitivity trials.
Table 1. Results of Sensitivity Trials
Growth at Each Concentration of H2O2
Mutant

0.258 mM

0.288 mM

0.318 mM

0.348 mM

Overall
Trend

iscS

iscU

tusA

tusC

tusD

tusE

mnmA

mnmE

mnmG

Severe

Severe

Severe

Moderate

Severe

Sensitivity

Sensitivity

Sensitity

Sensitivity

Sensitivity

Severe

Severe

Severe

Severe

Severe

Sensitivity

Sensitivity

Sensitivity

Sensitivity

Sensitivity

Severe

Severe

Severe

Moderate

Severe

Sensitivity

Sensitivity

Sensitivity

Sensitivity

Sensitivity

Severe

Severe

Moderate

Moderate

Severe

Sensitivity

Sensitivity

Sensitivity

Senstivity

Sensitivity

Severe

Severe

Moderate

Moderate

Severe

Sensitivity

Sensitivity

Sensitivity

Senstivity

Sensitivity

Mild

Mild

NA

NA

Mild

Sensitivity

Sensitivity

Severe

Mild

Moderate

Severe

Severe

Sensitivity

Sensitivity

Sensitivity

Sensitivity

Sensitivity

Mild

Moderate

Mild

Mild

Mild

Sensitivity

Sensitivity

Sensitivity

Sensitivity

Sensitivity

Resistant

Resistant

Mild

Mild

Mild

Sensitivity

Sensitivity

Sensitivity

Sensitivity
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mnmC

Resisitant

Resitant

Resistant

NA

Resistant

cyaY

Resitant

Resistant

Resistant

Resistant

Resistant

hscB

Resistant

Mild

Mild

Resistant

Mild

Sensitivity

Sensitivity

Mild

Resitant

Resistant

Resistant

Mild

Resitant

Resistant

NA

Mild

ycfC

Resistant

Sensitivity

Sensitivity
thiI

Resistant

Resistant

Sensitivity
ytfE

miaA

Fdx

Moderate

Mild

Sensitivity

Sensitivity

Resistant

Moderate

Mild

Mild

Mild

Sensitivity

Sensitivity

Sensitivity

Sensitivity

Resistant

Resistant

Mild

Resistant

Resistant

NA

Sensitivity

Sensitivity
rspA

tmcA

Dtd

Moderate

Mild

Mild

Sensitivity

Sensitivity

Sensitivity

Resistant

Moderate

Mild

Sensitivity

Sensitivity

Mild

Mild

sensitivity

sensitivity

Resistant

Resistant

Mild
Sensitivity

Resistant

Mild
Sensitivity

Resistant

Resistant

yeaK

Resistant

Resistant

Resistant

Resistant

Resistant

lysU

Resistant

Resistant

Resistant

Resistant

Resistant
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This table shows the sensitivity levels of each gene that was tested against hydrogen
peroxide over the course of the experiment. Every gene was examined at each concentration of
hydrogen peroxide, and the mutant’s level of sensitivity was determined based on its level of
growth. The possible evaluations are: Resistant (no impact on growth), Mild Sensitivity (growth
slightly less than control), Moderate Sensitivity (growth significantly less than control), and Severe
Sensitivity (growth either absent or minimally present relative to control).
A brief computational analysis of several genes featured in the sensitivity screens above is
feautured in the Computational Analysis section below.
The table below contains the data from the RNA extraction and subsequent nanodrop
analysis. This particular RNA came from E. coli with the dtd gene knocked out.

Table 2. RNA Extraction Data
Tube
A
B
C
D
E
F

260:280 260:230
2.00
1.94
2.00
1.88
1.94
1.67
2.01
1.56
1.94
1.22
1.98
1.45

ng/µL
1385.7
634.3
2113.3
890.1
945.6
1101.2

H2O2
+
+
+
-

This table shows the results of RNA extraction from Dtd knockouts. There are six total
tubes of extracted RNA, three with hydrogen peroxide and three without. The tubes all had values
for DNA contamination that indicate purity (~2.00), and tube C had an especially high
concentration. Unfortunately, tubes C-F had an undesirably low value for 260/230, indicating that
they are likely contaminated by ethanol or propanol. Tubes A and B produced the best results
overall, with good purity values and workable concentrations. If future projects are done with this
extracted RNA, they will be performed with tubes A and B.
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Computational Analysis
Basic Local Alignment Search Tool, better known as BLAST, is a computational tool
that can be used to analyze both nucleotide and protein sequences. For this research, the National
Institute

of

Health’s

BLAST

tool

was

used;

it

can

be

accessed

at

https://blast.ncbi.nlm.nih.gov/Blast.cgi (McGinnis & Madden, 2004). BLAST works by taking 3
letter “words” from the input sequence which are then compared against another sequence of
interest to find matching areas. The program finds a particular alignment between the two
sequences that produces the highest number of matching words. It then extends the sequence from
the matching sites, determining along the way whether each extended letter matches the input
sequence (and therefore improves the alignment) or does not match (and therefore decreases the
alignment). The program then returns data about the alignments produced, with several outputs of
note. Percent identity describes how much of two sequences are the same, with two identical
sequences having a percent identity of 100%. E-value describes the statistical likelihood that the
number of matches in the alignment was due to chance. For example, an e-value of 1 would
indicate that you could expect 1 match due entirely to chance. Lower e-values generally represent
more significant alignments, as they indicate that the results were less attributable to chance. Query
Cover Percentage shows the portion of the two sequences that are covered by the alignment
produced. If an alignment covered 15 out of 20 total base pairs, for instance, the Query Cover
would be 75% (Madden, 2013).
An Orthologous Gene is a gene that shares a similar evolutionary history or function with
another gene in another organism. Finding orthologs can be useful for determining organisms’
evolutionary relatedness or for determining the generalizability of experimental results (i.e.
orthologs in different species may react similarly in similar conditions). The EcoCyc Database has
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a search tool specifically designed to find orthologs between species. It uses gene ontology termswhich are a standardized way of describing gene functions and products- to identify potential
orthologous genes in the genomes selected by the user (Ashburner et al., 2001). For the purposes
of this inquiry, the human genome was selected.
Table 3 shows the results of both the BLAST searches and the EcoCyc Ortholog search.
The first three columns of data refer to blastp (comparison of protein sequences to human proteins).
There is only one column dedicated to blastn (comparison of nucleotide sequences to the human
genome), as all of the results were negative and thus easily summarized with one data point. Given
the positive results from the blastp, the negative results from the blastn are curious; this will be
discussed below.
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Table 3. BLAST Results
Gene

Query %

E-value

% Identity

blastn

EcoCyc

Human Gene

dinB (+)

77

2E-45

33.43

-

-

POLK

miaA

87

1E-30

29.32

-

-

TRIT10

mnmE

98

3E-77

36.40

-

-

GTPBP3

yeaK

-

-

-

-

-

-

tsaE

-

-

-

-

-

-

dtd

99

4E-26

39.46

-

-

DTD1

tmcA

51

1E-23

24.79

-

-

NAT10

pheS

83

6E-35

29.87

-

-

FARSA

Random (-)

-

-

-

-

-

-

The data from this chart suggests that there are potential human orthologs to 5 of 8 of our
bacterial genes. However, only two of these genes- mnmE and dtd- match or exceed the E-value
and Percent Identity values set by the positive control (dinB). This control was chosen because the
gene encodes the highly conserved DNA polymerase IV and is known to have a human homolog
(Gerlach et al., 1999). While the other 3 genes (miaA, pheS, and tmcA) have data below the
threshold of the positive control, their E values are low enough to still consider them orthologs.
Two more interesting features of the chart are the blastn and EcoCyc columns, as both yielded all
negative results. For blastn, it seems likely that the species compared (E. coli and humans) are too
evolutionarily distinct to produce a common DNA sequence- there has simply been too much time
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for mutations to occur and alter the sequence. It is interesting, however, that the protein sequencesand therefore, the functions of the gene- do produce a significant similarity in spite of the DNA
dissimilarity. This is likely a testament to wobble pairing and the multitude of codon options for
each amino acid. As for the EcoCyc search results, I suspect that the less-rigorous search
parameters (notably, the use of gene ontology terms rather than a defined sequence of nucleotides
or amino acids) make the tool ill-suited to comparing two extremely different organisms- like
bacteria and humans. However, I believe that it retains functionality for similar organisms, as it
generates very specific results about orthologous genes in bacteria to bacteria comparisons.
Another BLAST analysis was conducted based on the results of the sensitivity screens
found above. Three of the genes that showed a consistent sensitivity to hydrogen peroxide, iscS,
tusA, and mnmA, were chosen to be tested. The analysis compared the nucleotide sequence of each
gene against the human genome to identify orthologs. The results are shown in the table below.
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Table 4. BLAST Analysis of Sensitive Genes
Gene

Query %

E-value

% Identity

Human Gene Name

dinB (+)

77

2E-45

33.43

POLK

iscS

45

1E-20

64.96

NFS1

tusA

-

-

-

-

mnmA

-

-

-

-

Random (-)

-

-

-

-

Of the three genes tested, only one- iscS- returns any similarity to a human gene. The query
percent and e-value are lower than the positive control, but they are still quite high. Combined
with the high percent identity, these results indicate that the NFS1 gene is an ortholog of iscS.
Another database used to evaluate genes was The National Cancer Institute’s GDC Data
Portal. This database is specifically dedicated to cancer data, and it can be used for a variety of
operations involving the association of certain cancers with particular genes and the comparison
of demographic data, diagnosis information, treatment information, and exposure history of the
patients with those particular genes. Of particular interest is the data that describes which
percentage of patients in a cohort had single nucleotide variations, copy number variations, or
methylation in a gene of interest. A high percentage may indicate that that gene plays a role in
cancer development. The following graphs show the result of a comparison operation performed
within the database. It compares the survival rates over time of all patients with a mutation (a
simple somatic mutation, which is a change in a single base pair) in the human ortholog of one of
my experimental genes to a positive control dataset composed of all patients with a mutation
(simple somatic) in several genes with known connections to cancer. This set of genes is composed
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of the following: TP53, which creates a tumor suppressor protein to stops cells from growing
uncontrollably; EGFR, which codes for a growth factor receptor that can lead to tumor growth
when overexpressed; BRCA2, which is responsible for another tumor suppressor that is involved
with double strand break repairs and can lead to cancer if its DNA-repair activity is disrupted;
RAF1, which encodes a signaling enzyme that can prevent apoptosis if disrupted and thus lead to
cancer; MYC, which codes for an enzyme that regulates cell cycle and cell growth and that can
cause cancer if not tightly controlled; and ROS1, which codes for a kinase growth factor that can
lead to cancer if not regulated (Jones et al., 2009; Kelly et al., 1983; Nicholson et al., 2001; Olivier
et al., 2010; Takeuchi et al., 2012; Todd & Wong, 1999; Yang, 2002). Also shown on each graph
is the Log-Rank Test P-value, which is a statistical measure used to compare survival rate in two
different patient populations (Damato & Taktak, 2007). The patient population for the gene of
interest varies between 461 and 969 individuals, as each gene analyzed has a different number of
associated cancer cases. The patient population for the cancer-related gene data is 3396
individuals, and this is standard across all five graphs.
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Figure 16a. DTD1 NCI Data (dtd)

Figure 16b. GTPBP3 NCI Data (mnmE)
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Figure 16c. FARSA NCI Data (pheS)

Figure 16d. NAT10 NCI Data (tmcA)
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Figure 16e. TRIT1 NCI Data (miaA)
(a-e) NCI Survival Plots. In each graph, the blue line shows the survival rate of patients whose
cancer had at least one simple somatic mutation. Each graph shows data for a different gene, and
the gene shown is listed in the Figure’s title. The yellow line is standardized across all five graphs
and represents the survival rate of patients with at least one simple somatic mutation in the cancerrelated genes listed previously- these are genes that are known to be associated with cancer, and
thus serve as a positive control. For all five genes of interest, the most common mutation was a
simple somatic mutation that resulted in a nucleotide substitution, usually leading to missense and
a deletion of the gene’s product. The first three graphs all show similar shapes, but- noting their
relatively high p-values- their similarity is likely not statistically significant. The p-value is a
statistical measure that describes the likelihood of finding a particular result by chance
(Wasserstein & Lazar, 2016). A small p-value means that a result is less likely to be produced
randomly. The latter two graphs, for the orthologs of TmcA and MiaA respectively, have low
enough p-values (> 0.05) to consider them to have a statistically significant difference- one that
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potentially shows a higher survival rate- compared to the known cancer-causing dataset. Based on
this, I further evaluated TmcA and MiaA in another database for further cancer information. Given
the potentially higher survival rate in the NCI data, I expected to find that high expression of the
genes would lead to a higher survival rate in the HPA data.
For the genes that produced significant results in both the BLAST and NCI testing, further
computational work was done. The Human Protein Atlas is a database that contains information
on human genes and their protein products (Pontén et al., 2008). It can be used to obtain data on
tissue and cell localization, connections to the brain and blood, and- in the following data- potential
involvement with cancer. The following set of graphs shows the types of cancer in which the level
of TmcA and MiaA expression was correlated with a significant difference (as determined by the
database) in survival rate. Cases with high expression of the gene are shown by the pink line and
low expression is shown by the blue line.
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Figure 17. HPA Cancer Data
The first row of three graphs represents TmcA and the second row of graphs is for MiaA. The pink
line in each graph shows the survival rate for patients with a high expression of the gene, while
the blue line shows the survival rate for patients with a low expression of the gene. The graphs
show that, for three different types of cancer per gene, high expression of the gene is associated
with a lower survival rate over time. Two of these cancers, Liver and Renal, are shared between
the two genes. While this is not enough evidence to draw any conclusions from, it is an interesting
observation that could be the subject of future inquiries.
The HPA also contains data on the human brain. All five genes with human homologs were
classified as having “low regional specificity” in the human brain (determined on the basis of
expression data from the GTEx and FANTOM5 transcriptomics datasets), likely indicating that
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they are not heavily involved with brain processes (Kawaji et al., 2017; Lonsdale et al., 2013).
This is not definitive evidence, but I would expect a protein product that causes a brain disease to
be localized to a specific region of the brain upon which it would act.

Figure 18a. DTD1 Brain Localization (dtd)

Figure 18b. GTPBP3 Brain Localization (mnmE)

Figure 18c. FARSA Brain Localization (pheS)
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Figure 18d. NAT10 Brain Localization (tmcA)

Figure 18e. TRIT1 Homolog Brain Localization (miaA)

(a-e) HPA Brain Localization Data. These charts show that each gene has a low regional
specificity in each of the species for which data is available. This does not totally rule out
involvement in brain disease, as the protein products were still detected in the brain.
The EcoCyc Ortholog Search Tool was used to identify orthologous genes present in
other species of bacteria. Shown below in Figure 12 are the results of a search that compared three
genes in E. coli to the genomes of several other bacteria- chosen for their roles in causing diseaseto identify potential targets for antibiotics.
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Figure 19. EcoCyc Query Results (Zhang et al., 2000)
The tables above are the result of three separate bacteria-to-bacteria genome comparisons that
searched for orthologs in the EcoCyc database. These comparisons identified enzymes similar in
function MnmE, MiaA, and Dtd in several pathogenic bacteria. The query results show that
orthologous genes can be found in strains of bacteria that cause diseases such as tuberculosis,
typhoid fever, cholera, Lyme disease, chlamydia, and the plague. Note that Homo sapiens was
included in each of these queries, but it did not return any orthologs. As previously discussed, this
is likely due to the EcoCyc ortholog search tool’s weakness with regards to vastly different species.
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Figures 20-36, Table 5, and Table 6 were obtained using STRING, with Figures 20-34
being individual writer networks and Figures 35 and 36 being compilations of these individual
networks.

Figure 20. TRMO
This figure shows the interaction network for TRMO. The table indicates involvement in tRNA
modification.

TRMO

is

a

methyltransferase

threonylcarbamoyladenosine modification.
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that

creates

the

N6-methyl-N6-

Figure 21. CDK5RAP1
This figure shows the interaction network for CDK5RAP1. The tables show a general connection
to tRNA modification. CDK5RAP1 catalyzes the conversion of N6-dimethylallyladenosine to 2methylthio-N6-dimethylallyladenosine.
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Figure 22. SARS2
This figure shows the interaction network for SARS2. The tables show ligase activity and
involvement with selenocysteine. The network itself is mostly composed of ligase-family genes.
SARS2 is a serine ligase.

61

Figure 23. SARS
This image shows the interaction network for SARS. The network has several ligase-family genes.
The tables show an involvement with selenocysteine and ligase activity. SARS is a serine ligase.
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Figure 24. KARS
This network is very tight and contains mostly ligases. The tables also indicate ligase activity, and
there are also two stress responses mentioned in the upper table. KARS is a lysine ligase.
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Figure 25. NAT10
This network is also fairly tight. The overwhelming theme presented by the tables is that of
endonucleolytic cleavage. NAT10 catalyzes the formation of the N(4)-acetylcytidine modification.
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Figure 26. TRIT1
This figure is the interaction network for TRIT1. The tables indicate methyltransferase activity.
TRIT1 catalyzes the transfer of a dimethyl group to the form an N6-dimethylallyladenosine
modification.
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Figure 27. DUS4L
This is the interaction network for DUS4L. The tables show methyltransferase activity. DUS4L
catalyzes the synthesis of dihydrouridine.
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Figure 28. MTRF1L
This highly interconnected network is focused mostly on mitochondria and ribosomes. MTRF1L
is a release factor that stimulates the protein’s separation from the ribosome-tRNA complex.
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Figure 29. TST
This network shows several kinds of transfer activity, such as sulfurtransferase and
aminotransferase. TST catalyzes the formation of several sulfur and iron compounds.

68

Figure 30. DTD2
This network’s most notable feature is its deacylase activity. DTD2 deacylates mischarged Daminoacyl-tRNAs.
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Figure 31. DTD1
This network’s most notable feature is its deacylase activity, though it also has a pair of ligases.
DTD1 also deacylates mischarged D-aminoacyl-tRNAs.
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Figure 32. GTPBP3
This network is generally involved in tRNA modification, with a potential focus on mitochondrial
tRNA. GTPBP3 helps create the 5-carboxymethylaminomethyl modification.

71

Figure 33. FARSB
This is another ligase network, with a particular focus on aminoacyl activity. FARSB is a
phenylalanine ligase.
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Figure 34. FARSA
This figure shows the network of FARSA. Based on the tables, it is mostly focused on ligase
activity. FARSA is a phenylalanine ligase.
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Figure 35. First Shell
This figure shows the interactions between the fifteen genes of interest. There are two primary
clusters, one up and to the left and the other towards the lower half and slightly to the right. Based
on the data in the previous figures, the upper cluster seems to be composed of genes with ligase
activity.
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Figure 36. Second Shell
This large network is a compilation of all fifteen of the individual networks previously shown.
Much like the smaller network in the previous figure, there appears to be two primary clusters of
interactions. The cluster on the right is composed of ligases, much like the upper cluster in the
previous figure. The cluster to the left is less clear in its function; however, the writers GTPBP3,
NAT10, and TRIT1 can be seen in this cluster, with DUS4L and CDK5RAP1 on the outer edges.
This set of genes is reminiscent of the lower cluster in the previous figure. Further analysis was
performed to evaluate these networks.
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Molecular Function

Biological Process

Table 5. Writers and their Functional Categories
Functional Categories
cellular nitrogen compound metabolic process
tRNA aminoacylation for protein translation
tRNA modification
seryl-tRNA aminoacylation
selenocysteinyl-tRNA(Sec) biosynthetic process
phenylalanyl-tRNA aminoacylation
aminoacyl-tRNA metabolism involved in translational fidelity
mitochondrial tRNA modification
mitochondrial gene expression
organic cyclic compound binding
nucleic acid binding
purine ribonucleoside triphosphate binding
transferase activity, transferring sulfur-containing groups
ion binding
anion binding
drug binding
aminoacyl-tRNA ligase activity
phenylalanine-tRNA ligase activity
serine-tRNA ligase activity
D-tyrosyl-tRNA(Tyr) deacylase activity

TST
NAT10
GTPBP3 DTD1
DTD2
SARS
8.72E-08 8.72E-08 8.72E-08 8.72E-08 8.72E-08 8.72E-08
2.68E-08
2.87E-09 2.87E-09
5.76E-05
1.30E-04

Writers
SARS2
KARS
FARSA
FARSB
TRIT1
DUS4L
MTRF1L CDK5RAP1 TRMO
8.72E-08 8.72E-08 8.72E-08 8.72E-08 8.72E-08 8.72E-08 8.72E-08 8.72E-08 8.72E-08
2.68E-08 2.68E-08 2.68E-08 2.68E-08
2.87E-09 2.87E-09
2.87E-09 2.87E-09
5.76E-05
1.30E-04
1.30E-04 1.30E-04

5.70E-04 5.70E-04
3.20E-04
1.60E-03
1.60E-03
3.50E-05 3.50E-05 3.50E-05 3.50E-05 3.50E-05 3.50E-05 3.50E-05 3.50E-05 3.50E-05 3.50E-05 3.50E-05 3.50E-05 3.50E-05
1.40E-04 1.40E-04
1.40E-04 1.40E-04 1.40E-04
1.40E-04 1.40E-04 1.40E-04 1.40E-04
1.40E-04
1.20E-04 1.20E-04
1.20E-04 1.20E-04 1.20E-04 1.20E-04 1.20E-04 1.20E-04
5.00E-03
3.50E-03 3.50E-03 3.50E-03
3.50E-03 3.50E-03 3.50E-03 3.50E-03 3.50E-03 3.50E-03
2.10E-04 2.10E-04
2.10E-04 2.10E-04 2.10E-04 2.10E-04 2.10E-04 2.10E-04 2.10E-04
5.30E-04
5.30E-04 5.30E-04 5.30E-04 5.30E-04 5.30E-04 5.30E-04
8.07E-09 8.07E-09 8.07E-09 8.07E-09 8.07E-09
5.89E-05 5.89E-05
3.50E-05 3.50E-05
3.50E-05 3.50E-05

3.20E-04
1.60E-03

5.00E-03
3.50E-03

This table shows the false discovery rate for each writer that is associated with a particular
biological process or molecular function; the process of its creation was described in the Materials
and Methods section. Seen in the first row, “Cellular Nitrogen Compound Metabolic Process” is
associated with every writer. Other functions of particular interest are “Organic Cyclic Compound
Binding” and “tRNA Modification.” The ligase writers (SARS, SARS2, KARS, FARSA, and
FARSB) are grouped together for several functions that reference their ligase activity, such as
“tRNA Aminoacylation for Protein Translation” and “Aminoacyl-tRNA Ligase Activity.” The
functions that differentiate the writers within this group are mostly functions that relate to specific
tRNAs, such as “Seryl-tRNA Aminoacylation.” The writers outside of this group do not have a
similar unity, as there is not as clear a connection- aside from the previously mentioned “Cellular
Nitrogen Compound Metabolic Process” and “Organic Cyclic Compound Binding.” These
particular functions stand out compared to the more expected tRNA modification-related
functions, and they will be discussed further in the Discussion section.
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Table 6. Metabolic Processes

This image shows data from STRING on several metabolic processes associated with the second
compilation network. The processes of interest are highlighted. The column to the far right is false
discovery rate, and both processes of interest have low enough values to be considered significant.
The third column from the right is Count in Network; the first value is the number of associated
genes in this particular network and the second number is the total number of genes associated
with the process, both in the network and otherwise. The implications of this image are explained
in the Discussion section.
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Discussion
As for the results of the sensitivity trials, the sensitivity of iscS and tusA indicates that the
broad field of sulfurtransferase activity is involved with the oxidative stress response. However,
these results alone do not connect the specific subject of tRNA modification. The sensitivity of
mnmA is a more promising indication that sulfurtransfer with regards to tRNA modification is
critical to oxidative stress response. This is due to mnmA’s closer proximity to the tRNA
modification in the sulfurtransferase pathway. To more throughly investigate the implications of
the sensitivity screens, a brief discussion of each sensitive gene is needed. Based on their relative
lack of growth, the following E. coli strains exhibited a potential sensitivity to oxidative stress:
iscS, iscU, miaA, mnmE, mnmA, tusA, tusC, and tusD. The Table 1 shows a compilation of the
results of the sensitivity trials.
The gene iscS is a cysteine desulfurase that transfers sulfur from cysteine to other
molecules including tRNA; it is also important for the repair of iron-sulfur clusters (Mihara et al.,
2000). In the sensitivity screens, iscS showed a consistent and drastic lack of growth in the presence
of hydrogen peroxide. This potentially indicates a connection between tRNA and oxidative stress,
but this connection is not definitive due to iscS’s broad range of functions.
The gene iscU is a close relative of iscS, and it acts as a scaffold protein for the transfer of
sulfur during the assembly of iron-sulfur clusters (Kim et al., 2015). It showed a high sensitivity
to oxidative stress, similar to iscS. While it is involved in sulfurtransferase activity, that role is not
necessarily directly related to tRNA modification. Thus, iscU’s sensitivity could be evidence of a
broader sulfurtransferase/oxidative stress argument, but it could not be used as a point of connectio
to tRNA modification. For that purpose, other genes are better suited.
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The gene miaA transfers a dimethylallyl group to the N6 position of A37 on tRNATyr and
tRNAPhe (Bartz et al., 1970). The growth of miaA showed some sensitivity, but this growth pattern
was not consistent. Thus, there is a potential sensitivity that cannot be stated definitively. If the
sensitivity is indeed present, then there is a connection between the dimethylallyl modification and
oxidative stress response. The modification has regulational function, as it assists in the prevention
of frameshift mutations (Urbonavicius, 2001).
The gene mnmE is responsible for the specific tRNA modification 5-methylaminomethyl2-thiouridine (Elseviers et al., 1984a). It shows moderate sensitivity to hydrogen peroxide. The
modification is involved in maintaining the proper reading frame- a somewhat similar function to
that of miaA (Brégeon et al., 2001). Also of note, mnmE is downstream of iscS and is thus reliant
on sulfurtransferase activity, potentially connecting that activity to oxidative stress response.
The gene mnmA catalyzes the 2-thiouridine modification on the wobble position of
tRNAGln , tRNAGlu , and tRNALys (Kambampati & Lauhon, 2003). It relies on the delivery of a
sulfur atom via the aforementioned iscS and the soon-to-be-discussed tus family (Ikeuchi et al.,
2006a). In the sensitivity trials, mnmA showed a strong sensitivity to hydrogen peroxide,
suggesting that its sulfurtransferase function could be critical to oxidative stress response. The
inconclusivity of mnmE’s results could be used to counter this argument, but the sensitivity could
be specific to a particular modification that mnmE is not responsible for.
The gene tusA is a sulfur mediator that interacts with iscS upstream of mnmA, eventually
leading to the synthesis of the 2-thiouridine modification (Ikeuchi et al., 2006b). It shows a
sensitivity to hydrogen peroxide in the growth trials, which is consistent with the results of iscS
and mnmA.
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The relatives of tusA, tusC and tusD, act as intermediaries between tusA and mnmA
(Numata et al., 2006). They also show a growth sensitivity. These results, combined with the
results of iscS, tusA, and mnmA create a consistent pattern of sensitivity to oxidative stress along
the tRNA sulfur modification pathway. Consider the following image, reproduced from Figure 8:

Figure 8. Sulfurtransferase Pathway (Kambampati & Lauhon, 1999).
This image shows the pathway that leads to the transfer of sulfur to tRNA. At the beginning, on
the left side of the image, iscS is shown. Immediately after is tusA, with the rest of the tus family
following immediately downstream. MnmA and several other mnm family genes are found at the
end of the pathway. These genes were part of this experiment’s investigation into the sensitivity
of E. coli to hydrogen peroxide.
The lower portion of the diagram shows the process by which sulfur atoms are transferred
to various tRNA modifications. The genes involved are the isc, tus, and mnm families. Elements
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from each of these groups have shown a consistent sensitivity to hydrogen peroxide, likely
indicating that this pathway is involved in the oxidative stress response.
Following the sensitivity screens, a BLAST analysis was performed. Three genes were
selected: iscS, tusA, and mnmA. Each of these genes showed a consisitent and acute sensitivity
during the trials; additionally, they represent each of the three primary gene families involved in
the sulfurtransferase pathway. The results of this BLAST analysis are found in Table 4. Only one
gene, iscS, had a human ortholog, which was found to be NFS1. This gene is a cysteine desulfurase,
meaning that it is also involed in a sulfur-related process. It is also known to be involved in several
oxidative phosphorylation deficiency disorders, which provides a potential indicator for the
mechanism behind the sensitivity of the sulfurtransferase pathway: if the pathway begun by iscS
is indirectly needed for oxidative phosphorylation, then interference in that pathway could also
interfere with the cell’s ability to produce energy. This would be particularly harmful during a
stress response, leading to the sensitivity of the knockouts. This hypothesis would require more
data to be confirmed.
I have also performed computational analysis to identify orthologs to my genes of interest
in both humans and in several varieties of pathogenic bacteria. For the genes with human orthologs,
I will describe potential connections to cancer. For the three genes that were ortholog-searched
against bacteria, I will describe several of the diseases that could potentially be treated using
antibiotics that target those genes.
As for the ortholog searches for the newest four genes, two were determined to have human
equivalents. The BLAST data suggests that YeaK and TsaE do not have human orthologs, but
TmcA and PheS do have human orthologs: NAT10 and FARSA, respectively.
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NAT10 is a protein coding gene involved in histone acylation and telomerase regulation
(Liu et al., 2007). These activities are both highly involved in the upkeep of DNA, so it comes as
no surprise that NAT10 has been shown to be upregulated in response to DNA damage. In fact,
the expression of NAT10 was found to increase in the presence of hydrogen peroxide (Liu et al.,
2007). Based on this, I believe that it is highly likely that TmcA is also involved in oxidative stress
response and E. coli will exhibit a sensitivity to hydrogen peroxide when TmcA is knocked out.
FARSA performs the same function in humans as PheS does in bacteria; it encodes for the
alpha subunit of the PheRS complex responsible for binding tRNA to phenylalanine (Krenke et
al., 2019). An inhibition of this function would disrupt translation by limiting the amount of
phenylalanine available for peptide construction. This would likely result in a sensitivity to stress,
as any upregulated protein that contains phenylalanine would be compromised.
These two genes were examined in several databases along with the original three genes
(MiaA, MnmE, and Dtd), as the latter three were also found to have human equivalents. Data from
the NCI compared the survival rates of patients with single nucleotide changes or copy number
variations in each gene to the survival rates of patients with single nucleotide changes or copy
number variations in a set of known cancer-related genes. This data indicates that the human
orthologs of MiaA and TmcA are potentially connected to a higher survival rates in cancer patients,
as there was a statistically significant difference between their individual survival rates and the
survival rate of a set of cancer-causing genes used as a control. However, data from the HPA
indicates that high expression levels for both genes are correlated with a lower survival rate for
patients with cancers in the Liver and Renal categories. This is a curious result, as the two genes
were associated with higher survival rates in the NCI data. It is possible that the two genes may be
associated with higher survival overall, but they are associated with lower survival in certain types
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of cancer- as shown in the HPA data. While the modifications catalyzed by these two genes do not
act on the same position on the tRNA molecule, they are nearby. They act on the 34 and 37
positions, which are both quite close to the anticodon loop. A loss of modification for either
position could compromise wobble pairing or codon-anticodon binding as a whole, thus disrupting
translation. Translation would likely not be wholly halted, as neither gene acts on all forms of
tRNA, but there would likely be a larger possibility for error due to the loss of specified binding
activity on the 34 and 37 positions. Based on the HPA data and the similar location of the TmcA
and MiaA-catalyzed modifications, I believe there could potentially be a link between Liver and
Renal cancers and disruption of the anticodon loop. More in-depth research would be necessary to
test this hypothesis.
Perhaps the most famous example of an infectious disease is the Plague (bubonic,
septicemic, and pneumonic varieties), caused by the bacteria Yersinia pestis. The bacteria are
typically transmitted to humans by fleas from infected rodents, but it can also be transmitted by
droplets or direct contact with infected blood. Once in the body, the bacteria establish an infection
in the lymph nodes, blood, or lungs (the location determines the type of Plague). The bacteria then
begin to replicate rapidly and spreads throughout the body (Perry & Fetherston, 1997). Plague is
treated with the antibiotic’s streptomycin, doxycycline (both of which bind the 30S subunit of the
ribosome, inhibiting protein synthesis (Maaland et al., 2013; Sharma et al., 2007), or ciprofloxacin
(which inhibits DNA gyrase, stopping cell division (Drlica & Zhao, 1997), sometimes with the
assistance of intravenous fluids. This treatment must be given very soon after the infection, as the
disease is highly virulent (Apangu et al., 2017). Yersinia pestis contains the genes dtd and mnmE,
so an antibiotic could be created to target these genes. Inhibiting the Dtd protein would allow dtyrosine to be incorporated into proteins, which could result in cell death from a scarcity of

83

functional proteins. Inhibition of MnmE would disrupt wobble pairing by destabilizing U-G
interactions and allow for more reading frame mutations, possibly interfering with the base-pair
monitoring function of the 30S subunit.
For a more common example of an infectious disease, we can look at chlamydia and its
causative bacteria, Chlamydia trachomatis. The bacteria enter the body during sex and typically
infects the columnar epithelium of the cervix, urethra, and rectum- though it can also infect the
lungs and the eyes. Left untreated, the bacteria will continue replicating and lead to complications
in the infected region (pelvic inflammatory disease and infertility are possibilities). The treatment
consists of the antibiotic’s azithromycin (which binds the 50S ribosomal subunit, inhibiting protein
synthesis (Parnham et al., 2014)) and doxycycline, which are a one-time dose or a several-day
course, respectively (Paez-Canro et al., 2013). Chlamydia trachomatis contains the mnmE and
miaA genes, so an antibiotic targeting either corresponding protein could be effective. Inhibition
of MiaA could prevent tRNATyr from effectively binding the 30S subunit, potentially disrupting
protein synthesis.
Particularly relevant in Upstate New York is Lyme Disease, which is caused by Borrelia
burgdorferi. The bacteria is transmitted to humans by a tick vector. Upon infection via tick bite,
the infection is initially localized to the bite area, but later disseminates throughout the body.
Antibiotics such as doxycycline and amoxicillin (which lyses bacterial cell walls (Akhavan &
Vijhani, 2019) are used for treatment, though the exact treatment varies depending on the stage of
infection. Non-steroidal anti-inflammatory drugs are also used when needed for symptom relief
(Taylor & Simpson, 2005). Similar to the previous example, Lyme Disease could potentially be
treated by an antibiotic that targets MnmE or MiaA, as both of these genes are found in Borrelia
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burgdorferi. Inhibition of MnmE and MiaA would disrupt protein synthesis, theoretically similar
in result to doxycycline.
Tuberculosis, caused by Mycobacterium tuberculosis, is a particularly interesting example
due to the concerns over drug-resistant strains. It is primarily transmitted by aerosol droplets that
enter the lungs and contact the alveoli. The bacteria is contained in granuloma, small pockets
formed by the immune system to stop the spread of the disease. These often burst during heavy
breathing, however. Tuberculosis is treated using a very long course of multidrug antibiotic
treatment that can include a combination of rifampicin (which inhibits RNA polymerase (Calvori
et al., 1965)), streptomycin, isoniazid (which inhibits cell wall synthesis (Timmins & Deretic,
2006), pyrazinamide (which inhibits multiple targets (Zhang et al., 2014), and ethambutol (which
depletes metabolites (Forbes et al., 1962). The extensive use of antibiotics leads to the
aforementioned concerns over disease resistant strains, which in turn leads to the need for more
antibiotic options to treat the drug resistant strains (Frieden et al., 1993) The bacteria
Mycobacterium tuberculosis contains both dtd and miaA, making both corresponding proteins
potential targets for antibiotics. Inhibition of either Dtd or MiaA would interfere with protein
synthesis, possibly providing an alternative approach to the antibiotics listed above.
The results of my analysis of fifteen human writers are mostly in line with my predictions;
the writers are involved in tRNA modification and ligase activity, with some writers performing
other related activities. However, Table 5 shows two features that seem to break from this pattern:
“Cellular Nitrogen Compound Metabolic Process” and “Organic Cyclic Compound Binding.”
These functions are both associated with all or nearly all of the fifteen writers, but they are not
explicitly connected to tRNA modification or ligase activity. My initial hypothesis was that these
two functions were involved in the processing of some sort of nitrogen-based compounds uptaken

85

by the cell, but this would be a departure from the rest of the functions. I believe that these two
functions are not as radically different from the rest of the the functions as I initially thought. My
new hypothesis is that these two functions are simply an elaborate way of describing interaction
with genetic material. This explains both functions, as the critical purines and pyramidines all
contain nitrogen, and both these nitrogen bases and the nucleic acid component are organic cyclic
compounts. If this hypothesis is correct, I would expected that “Cellular Nitrogen Compound
Metabolic Process” and “Organic Cyclic Compound Binding” are nonspecific and broad
categories. Figure 30 was created to test this expectation. The Count in Network values for both
functions indicate that both functions are very broad categories, with thousands of associated
genes. This hypothesis is something of an anticlimax, as it eliminates the possibility of an outlier
function in the network. However, it is still productive because it clarifies the overall function of
the network and eliminates a source of uncertainty. The most important result of this network
analysis is that it connects the translational functions of the previously studied bacterial genes to
human genes, providing evidence that the results of the bacterial research can be generalized to
humans.
To summarize the work done, I began with a set of E. coli genes that are all functionally
related to tRNA modification. Computational work was done with STRING to create a network of
connection among these genes and identify related gene groups. Similar computational work with
BLAST was done to identify human orthologs of these genes. The existing orthologs were
investigated in several databases, which determined that they were likely not related to brain
disease but two- tmcA and miaA- may be connected to liver and renal cancer. Returning to the
original set of genes, oxidative stress sensitivity screens were performed on each individual gene
knockout. The knockouts that exhibited a growth sensitivity in the presence of oxidative stress
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(hydrogen peroxide was used for this experiment) were evaluated using STRING; from this
STRING network, new genes with a close relationship to the senstive gene were identified. The
newly selected genes were then put through their own sensitivity trial. This process was repeated
several times, ultimately surveying twenty two separate E. coli knockouts. Of these, iscS, iscU,
mnmA, tusA, tusC, and tusD were found to be severely sensitive to the hydrogen peroxide. Other
members of the mnm and tus families were mildly sensitive. These genes make up the majority of
a sulfur relay system that transfers sulfur molecules to tRNA for the synthesis of multiple tRNA
modifications. The sensitivity of these genes indicates that this sulfurtransfer pathway is involved
in the cellular response to oxidative stress. This knowledge could be used to inform further studies
to elucidate more specific information about the role of sulfurtransferases in the oxidative stress
response- and, from that, their potential role in cancer and aging.The data could be used in the
development of new antibacterial drugs targeting the sulfur relay system, with the goal of
compromising the bacteria’s ability to survive environmental and internal metabolic stress.
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Future Directions
Having identified several genes with a probable sensitivity to oxidative stress, the next step
would be to expand the scope of the investigation beyond oxidative stress. The sensitive genes
could be tested against a variety of other stressors. Heat shock, ultraviolet radiation, and methyl
methanesulfonate are all potential sources of stress. The purpose of these additional stressors
would be to investigate whether or not the sensitivity observed in the knockout strains is exclusive
to oxidative stress or is involved in stress response in general. In other words, it would determine
the level of specificity of the sensitive genes’ involvement in stress response.
One potential form of analysis that could be performed on the RNA that was extracted is
Liquid Chromatography-Tandem Mass Spectrometry (Petrović et al., 2005). In this process,
the analyte is placed in a liquid mobile phase and is passed through a column containing a solid
stationary phase. Chemical interactions between the phases causes the mobile phase to separate as
it moves down the column. As the analyte exits the column, it is directed to the mass spectrometry
device. This ionizes the analyte and passes it through a series of analyzers that determine the mass
to charge ratio for the particles. In addition to the experimental mutants, wild type RNA would be
analyzed to provide a baseline. Combining this with the experimental data would produce a
heatmap that shows the upregulation or downregulation of specific tRNA modifications. The
modification that an investigated knockout mutant encodes will presumably show a strong
downregulation in the heatmap. After observing several mutant’s heatmaps, I will look for any
patterns of modifications that are consistently upregulated or downregulated, as these patterns
would likely show a connection between different mutants or between certain modifications and
oxidative stress response.
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As for the human writers examined in the interaction network section, features of
connectivity could be assessed to determine if this function group is more connected than others.
One potential path to connect this work with the stress response work is to perform stress testing
on the bacterial orthologs of the human genes examined. The computational work established a
connection between the interaction network and ligase activity and tRNA modification; a
connection to oxidative stress could be established by stress testing bacterial knockouts in a similar
manner to the previously described stress tests. This would connect this phase of my project to the
earlier phases, as I described above that further stress tests would require new genes to be
identified; this computational analysis could serve as that identification method.
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